CD47 and hepatocellular carcinoma: It has been found that 4-methylumbelliferone (4Mu), the hyaluronan synthesis inhibitor, plays a role in promoting phagocytosis via downregulating CD47 expression on hepatic CSCs, and potentiating cytotoxic-specific T cell response against HCC induced by interleukin-12 (48).